Skip to main content

Table 1 Patient baseline inclusion characteristics according to treatment allocation

From: Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?

Variable Control patients (n = 30) SCT patients (n = 28) p value
Age (years) 57 (37–69) 54 (35–67) 0.15
Gender (M/F) 19/11 14/14 0.31
HVPG (mmHg) 19.9 ± 2.4 19.1 ± 2.8 0.28
MELD score 19.1 ± 4.0 19.0 ± 3.8 0.86
Cirrhosis (%) 100 100 0.99
ASH (n, %) 25 (83.3%) 22 (78.6%) 0.64
Corticosteroid treatment (n, %) 22 (73.3%) 16 (57.1%) 0.59
  1. ASH alcoholic steatohepatitis (full histological definition), F female, HVPG hepatic venous pressure gradient, M male, MELD model for end stage liver disease, SCT stem cell therapy